Literature DB >> 1968892

Staphylococcus aureus in patients with cystic fibrosis: an epidemiological analysis using a combination of traditional and molecular methods.

R V Goering1, A Bauernfeind, W Lenz, B Przyklenk.   

Abstract

An epidemiological analysis of Staphylococcus aureus was conducted in a study group of 157 cystic fibrosis patients cultured over a 30-month period. The resulting S. aureus isolates were categorized by bacteriophage type, plasmid profile, and (in some instances) chromosomal restriction fragment pattern of the culture-positive patients with S. aureus (34 of 157) 44% only were sporadically infected while 68% shared identical strains with one or more other patients. Six patients exhibited persistent infection (for up to ten months) which, in three individuals, occurred as cycles of carriage and reappearance. By contributing toward our understanding of the persistence and spread of S. aureus in cystic fibrosis patients these data should aid in clarifying the role this organism may play in the course of the disease.

Entities:  

Mesh:

Year:  1990        PMID: 1968892     DOI: 10.1007/bf01644187

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Rapid field inversion gel electrophoresis in combination with an rRNA gene probe in the epidemiological evaluation of staphylococci.

Authors:  R V Goering; T D Duensing
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 2.  Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.

Authors:  B C Michel
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

3.  Electrophoretic separations of large DNA molecules by periodic inversion of the electric field.

Authors:  G F Carle; M Frank; M V Olson
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

4.  A rapid boiling method for the preparation of bacterial plasmids.

Authors:  D S Holmes; M Quigley
Journal:  Anal Biochem       Date:  1981-06       Impact factor: 3.365

5.  Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

Authors:  A Bauernfeind; R M Bertele; K Harms; G Hörl; R Jungwirth; C Petermüller; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

6.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

7.  Comparative analysis of conjugative plasmids mediating gentamicin resistance in Staphylococcus aureus.

Authors:  R V Goering; E A Ruff
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

8.  Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.

Authors:  A Bauernfeind; G Hörl; B Przyklenk
Journal:  Scand J Gastroenterol Suppl       Date:  1988

9.  Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis.

Authors:  A Albus; J M Fournier; C Wolz; A Boutonnier; M Ranke; N Høiby; H Hochkeppel; G Döring
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

10.  Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis.

Authors:  N N Huang; D V Schidlow; T H Szatrowski; J Palmer; L R Laraya-Cuasay; W Yeung; K Hardy; L Quitell; S Fiel
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

  10 in total
  9 in total

1.  Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis.

Authors:  R V Goering; M A Winters
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Staphylococcus aureus escapes more efficiently from the phagosome of a cystic fibrosis bronchial epithelial cell line than from its normal counterpart.

Authors:  Todd M Jarry; Ambrose L Cheung
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Susceptibility to various antimicrobial agents and tolerance to methicillin of Staphylococcus aureus isolates from cystic fibrosis patients.

Authors:  A M Horrevorts; J W Mouton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

4.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

5.  Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells.

Authors:  Gabriel Mitchell; Mariza Gattuso; Gilles Grondin; Éric Marsault; Kamal Bouarab; François Malouin
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

6.  Selection of antibiotics for treatment and prophylaxis of staphylococcal infections in cystic fibrosis patients.

Authors:  A Bauernfeind; B Przyklenk; C Matthias; R Jungwirth; R M Bertele; K Harms
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

7.  Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal cystic fibrosis transmembrane conductance regulator function and is influenced by NF-κB.

Authors:  Gabriel Mitchell; Gilles Grondin; Ginette Bilodeau; André M Cantin; François Malouin
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 8.  Application of molecular techniques to the study of hospital infection.

Authors:  Aparajita Singh; Richard V Goering; Shabbir Simjee; Steven L Foley; Marcus J Zervos
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

9.  Epidemiology of Staphylococcus aureus in patients with cystic fibrosis.

Authors:  C Branger; J M Fournier; J Loulergue; A Bouvet; P Goullet; A Boutonnier; C de Gialluly; G Couetdic; M Chomarat; M C Jaffar-Banjee
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.